Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells

被引:92
作者
Papouli, E [1 ]
Cejka, P [1 ]
Jiricny, J [1 ]
机构
[1] Univ Zurich, Inst Mol Canc Res, CH-8006 Zurich, Switzerland
关键词
D O I
10.1158/0008-5472.CAN-04-0513
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mismatch repair (MMR) deficiency was reported to increase resistance of mammalian cells to killing by several genotoxic substances. However, although MMR-deficient cells are similar to100-fold more resistant to killing by S(N)1 type methylating agents than MMR-proficient controls, the sensitivity differences reported for the other agents were typically <2-fold. To test whether these differences were linked to factors other than MMR status, we studied the cytotoxicities of mitomycin C, chloroethylcyclohexyl nitrosourea, melphalan, psoralen-UVA, etoposide, camptothecin, ionizing radiation, and cis-dichlorodiaminoplatinum (cisplatin) in a strictly isogenic system. We now report that MMR deficiency reproducibly desensitized cells solely to cisplatin.
引用
收藏
页码:3391 / 3394
页数:4
相关论文
共 21 条
[1]  
Aquilina G, 1998, CANCER RES, V58, P135
[2]   Mismatch repair, G2/M cell cycle arrest and lethality after DNA damage [J].
Aquilina, G ;
Crescenzi, M ;
Bignami, M .
CARCINOGENESIS, 1999, 20 (12) :2317-2325
[3]  
Aquilina G, 2000, CLIN CANCER RES, V6, P671
[4]   hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. [J].
Brown, R ;
Hirst, GL ;
Gallagher, WM ;
McIlwrath, AJ ;
Margison, GP ;
vanderZee, AGJ ;
Anthoney, DA .
ONCOGENE, 1997, 15 (01) :45-52
[5]   Methylation-induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1 [J].
Cejka, P ;
Stojic, L ;
Mojas, N ;
Russell, AM ;
Heinimann, K ;
Cannavó, E ;
di Pietro, M ;
Marra, G ;
Jiricny, J .
EMBO JOURNAL, 2003, 22 (09) :2245-2254
[6]  
di Pietro M, 2003, CANCER RES, V63, P8158
[7]   Cisplatin and adriamycin resistance are associated with MutL alpha and mismatch repair deficiency in an ovarian tumor cell line [J].
Drummond, JT ;
Anthoney, A ;
Brown, R ;
Modrich, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (33) :19645-19648
[8]  
FANCHITTO A, 2003, ONCOGENE, V22, P2110
[9]   Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2 [J].
Fedier, A ;
Ruefenacht, UB ;
Schwarz, VA ;
Haller, U ;
Fink, D .
BRITISH JOURNAL OF CANCER, 2002, 87 (09) :1027-1033
[10]   Resistance to topoisomerase poisons due to loss of DNA mismatch repair [J].
Fedier, A ;
Schwarz, VA ;
Walt, H ;
Carpini, RD ;
Haller, U ;
Fink, D .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) :571-576